Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs17292069 | chr6:83603543 | C/T | 1.53E-14 | 132 | 43.68 | 33.88 | 4.78 | KM Plot |
| TGCT | rs17313059 | chr6:28333396 | T/C | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs17313276 | chr6:28337749 | G/A | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs173234 | chr17:39356271 | G/T | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs17339836 | chr7:128681062 | C/T | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs17340542 | chr7:128720045 | C/T | 1.67E-5 | 134 | 17.1 | 31.17 | 42.27 | KM Plot |
| TGCT | rs17393066 | chr6:28364793 | A/G | 9.11E-5 | 134 | 46.3 | 23.6 | 88.33 | KM Plot |
| TGCT | rs17424602 | chr7:128687940 | A/G | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs17535295 | chr5:1797350 | T/C | 4.04E-7 | 133 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs17535337 | chr5:1797432 | T/C | 4.04E-7 | 133 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs17535721 | chr5:1806653 | C/T | 5.82E-12 | 134 | 46.77 | 36.63 | 18.85 | KM Plot |
| TGCT | rs17599667 | chr19:30350666 | C/T | 0.000152 | 134 | 29.4 | 51.32 | 37.62 | KM Plot |
| TGCT | rs17678195 | chr16:83292805 | T/C | 1.81E-6 | 134 | 42.18 | 32.58 | 49.37 | KM Plot |
| TGCT | rs17687052 | chr6:15225528 | G/C | 7.25E-5 | 131 | 37.62 | 45.1 | NA | KM Plot |
| TGCT | rs17714259 | chr7:127147097 | T/A | 1.49E-5 | 134 | 42.1 | 37.53 | 100.87 | KM Plot |